REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 493 participants.

Also called NCT01483560

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 493 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01483560
  • EudraCT 2011-000300-18
Other papers using this trial's data
  • Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial The lancet. Diabetes & endocrinology, 2017-08 DOI, PubMed 28615149, PMC5641446 PubMed links an erratum for this paper. Erratum: PMID 28732665; Erratum: PMID 29082883 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Australia, Canada, Denmark, Netherlands, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01483560. Randomized; triple masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2017-03-19 (actual). Results posted on 2019-06-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Acronym
REMOVAL
Condition
Diabetes Mellitus, Type 1
Intervention (Drug)
Metformin
Intervention (Drug)
Placebo
Lead sponsor
University of Glasgow (class: other)
Collaborator
NHS Greater Glasgow and Clyde (class: other)
Collaborator
Juvenile Diabetes Research Foundation (class: other)
Collaborator
Imperial College London (class: other)
Collaborator
University of Wisconsin, Madison (class: other)
Collaborator
University of Dundee (class: other)
Collaborator
Merck Serono S.A., Geneva (class: industry)
Collaborator
Itamar-Medical, Israel (class: industry)
Collaborator
University of Western Ontario, Canada (class: other)
Collaborator
University of Melbourne (class: other)
Collaborator
Steno Diabetes Center Copenhagen (class: other)
Collaborator
Maastricht University Medical Center (class: other)

Record details

Record id
cardio:ct-nct01483560
Content hash
82ddd3452dad7d834adfc3363dc909ab19d850e810ab5028a7d816b1c5fc73bd